| MTEN 0.0401 13.60% | OCG 0.0104 -11.86% | SOXS 2.091 -8.29% | IVP 0.0581 -29.15% | APLT 0.1015 1.60% | BNKK 4.3093 55.01% | ZSL 3.0699 9.06% | SLV 81.2251 -3.94% | SOXL 60.085 8.50% | NVDA 186.66 1.92% | PTHL 0.3983 -9.44% | TQQQ 55.35 2.82% | PCLA 0.2039 -7.74% | INTC 49.95 2.52% | JTAI 0.4932 8.49% | DVLT 0.74 3.04% | MASK 0.3 -0.17% | TSLL 18.445 2.08% | OCUL 12.0799 9.12% | SIDU 3.8793 3.45% | BYND 1.105 14.88% | SXTC 0.1011 4.98% | ASST 0.9772 -5.13% | TSM 340.925 4.22% | MSTX 4.936 -5.08% | RILY 10.34 37.14% | SQQQ 65.05 -2.82% | AMD 232.6 4.03% | QQQ 625.485 0.96% | SAFX 0.1217 -11.36% | ASBP 0.0547 -6.81% | ROLR 21.4199 14.79% | GTBP 0.7257 9.95% | BMNR 32.07 -1.79% | CGTL 3.47 38.80% | SPY 694 0.53% | CRML 16.885 -5.80% | ASNS 0.4789 9.51% | NOK 6.635 4.32% | CRWV 96.8 7.80% | ONDS 13.42 -1.03% | IBIT 54.6242 -1.47% | ETHA 25.355 -0.92% | RGTI 25.88 0.62% | MU 339.62 1.88% | GPUS 0.3182 -0.50% | RZLV 4.139 1.95% | XLE 47.29 -1.60% | GRAB 4.56 -1.51% | PLUG 2.395 1.91%

MetLife Inc. (NYSE:MET) Quarterly Earnings Preview

MetLife Inc. (NYSE:MET) is set to release its quarterly earnings on November 5, 2025, after the market closes. Analysts have estimated an earnings per share (EPS) of $2.31, with revenue projected at $18.64 billion. MetLife is a leading global provider of insurance, annuities, and employee benefit programs, competing with companies like Prudential Financial and Aflac.

Analysts are optimistic about MetLife's performance, with the Zacks Consensus Estimate predicting an EPS of $2.33, a 20.7% increase from the previous year. This growth is driven by higher premiums, increased group benefits revenues, and strong international operations. Revenue is expected to reach $18.8 billion, reflecting a 7% year-over-year growth.

Despite these positive projections, MetLife faces challenges such as rising costs and weaker results in its Retirement and Income Solutions segment. These factors may temper profit gains. However, the earnings estimate has improved over the past month, indicating positive sentiment among analysts.

MetLife's financial metrics provide insight into its valuation and performance. The company has a price-to-earnings (P/E) ratio of approximately 12.43, showing the price investors are willing to pay for each dollar of earnings. The price-to-sales ratio is about 0.72, suggesting investors pay 72 cents for every dollar of sales.

The enterprise value to sales ratio is around 0.69, reflecting MetLife's valuation compared to its sales. The enterprise value to operating cash flow ratio is approximately 3.21, indicating how well the company can cover its enterprise value with its operating cash flow. The earnings yield is about 8.04%, providing insight into the return on investment for shareholders.

Published on: November 5, 2025